2-FMA: Difference between revisions
>Unity Standardize opening paragraph. |
>Unity m Grammatics |
||
Line 8: | Line 8: | ||
A substantial increase in negative effects like [[increased blood pressure|high blood pressure]] and [[increased heart rate]] is often reported for dosages above the heavy dosage range. | A substantial increase in negative effects like [[increased blood pressure|high blood pressure]] and [[increased heart rate]] is often reported for dosages above the heavy dosage range. | ||
2-FMA is commonly taken either orally or via insufflation as it has been reported to be highly unpleasant to vaporize | 2-FMA is commonly taken either orally or via insufflation as it has been reported to be highly unpleasant to vaporize. Despite its popularity as a research chemical study aid, little is known about any toxicity that may accompany its long-term use as a substitute for prescription stimulants. | ||
2-FMA has yet to be documented being sold on the streets and is instead typically sold by online vendors as a grey market [[research chemical]].<ref>Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues ([[designer drug]]s). (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/15639609</ref><ref>Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/20074881</ref> | 2-FMA has yet to be documented being sold on the streets and is instead typically sold by online vendors as a grey market [[research chemical]].<ref>Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues ([[designer drug]]s). (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/15639609</ref><ref>Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/20074881</ref> |